Literature DB >> 19696409

iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism.

Almudena Martinez-Fernandez1, Timothy J Nelson, Satsuki Yamada, Santiago Reyes, Alexey E Alekseev, Carmen Perez-Terzic, Yasuhiro Ikeda, Andre Terzic.   

Abstract

RATIONALE: Induced pluripotent stem cells (iPS) allow derivation of pluripotent progenitors from somatic sources. Originally, iPS were induced by a stemness-related gene set that included the c-MYC oncogene.
OBJECTIVE: Here, we determined from embryo to adult the cardiogenic proficiency of iPS programmed without c-MYC, a cardiogenicity-associated transcription factor. METHODS AND
RESULTS: Transgenic expression of 3 human stemness factors SOX2, OCT4, and KLF4 here reset murine fibroblasts to the pluripotent ground state. Transduction without c-MYC reversed cellular ultrastructure into a primitive archetype and induced stem cell markers generating 3-germ layers, all qualifiers of acquired pluripotency. Three-factor induced iPS (3F-iPS) clones reproducibly demonstrated cardiac differentiation properties characterized by vigorous beating activity of embryoid bodies and robust expression of cardiac Mef2c, alpha-actinin, connexin43, MLC2a, and troponin I. In vitro isolated iPS-derived cardiomyocytes demonstrated functional excitation-contraction coupling. Chimerism with 3F-iPS derived by morula-stage diploid aggregation was sustained during prenatal heart organogenesis and contributed in vivo to normal cardiac structure and overall performance in adult tumor-free offspring.
CONCLUSIONS: Thus, 3F-iPS bioengineered without c-MYC achieve highest stringency criteria for bona fide cardiogenesis enabling reprogrammed fibroblasts to yield de novo heart tissue compatible with native counterpart throughout embryological development and into adulthood.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696409      PMCID: PMC2785796          DOI: 10.1161/CIRCRESAHA.109.203109

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  47 in total

1.  Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes.

Authors:  Carmen Perez-Terzic; Atta Behfar; Annabelle Méry; Jan M A van Deursen; Andre Terzic; Michel Pucéat
Journal:  Circ Res       Date:  2003-01-30       Impact factor: 17.367

2.  Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload.

Authors:  S Izumo; B Nadal-Ginard; V Mahdavi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

3.  Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis.

Authors:  G Xiao; S Mao; G Baumgarten; J Serrano; M C Jordan; K P Roos; M C Fishbein; W R MacLellan
Journal:  Circ Res       Date:  2001-12-07       Impact factor: 17.367

4.  Stem cell differentiation requires a paracrine pathway in the heart.

Authors:  Atta Behfar; Leonid V Zingman; Denice M Hodgson; Jean-Michel Rauzier; Garvan C Kane; Andre Terzic; Michel Pucéat
Journal:  FASEB J       Date:  2002-10       Impact factor: 5.191

5.  The c-myc proto-oncogene regulates cardiac development in transgenic mice.

Authors:  T Jackson; M F Allard; C M Sreenan; L K Doss; S P Bishop; J L Swain
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

6.  Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2-dependent pathway.

Authors:  Weiguang Zhong; Songyan Mao; Scott Tobis; Ekaterini Angelis; Maria C Jordan; Kenneth P Roos; Michael C Fishbein; Ignacio Moreno de Alborán; W Robb MacLellan
Journal:  EMBO J       Date:  2006-08-10       Impact factor: 11.598

7.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

8.  Stable benefit of embryonic stem cell therapy in myocardial infarction.

Authors:  Denice M Hodgson; Atta Behfar; Leonid V Zingman; Garvan C Kane; Carmen Perez-Terzic; Alexey E Alekseev; Michel Pucéat; Andre Terzic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08       Impact factor: 4.733

9.  c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression.

Authors:  Troy A Baudino; Catriona McKay; Helene Pendeville-Samain; Jonas A Nilsson; Kirsteen H Maclean; Elsie L White; Ann C Davis; James N Ihle; John L Cleveland
Journal:  Genes Dev       Date:  2002-10-01       Impact factor: 11.361

10.  Induced pluripotent reprogramming from promiscuous human stemness related factors.

Authors:  Timothy J Nelson; Almudena Martinez-Fernandez; Satsuki Yamada; Amber A Mael; Andre Terzic; Yasuhiro Ikeda
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

View more
  61 in total

Review 1.  Stem cell therapy for ischemic heart disease.

Authors:  Mohammad Nurulqadr Jameel; Jianyi Zhang
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

Review 2.  De novo myocardial regeneration: advances and pitfalls.

Authors:  Khawaja Husnain Haider; Stephanie Buccini; Rafeeq P H Ahmed; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2010-10-12       Impact factor: 8.401

3.  Stem cell update: highlights from the 2010 Lugano Stem Cell Meeting.

Authors:  Silvana Bardelli; Giuseppe Astori; Daniel Sürder; Tiziano Tallone; Andre Terzic; Gianni Soldati; Tiziano Moccetti
Journal:  J Cardiovasc Transl Res       Date:  2010-10-30       Impact factor: 4.132

4.  ATP-sensitive K(+) channel-deficient dilated cardiomyopathy proteome remodeled by embryonic stem cell therapy.

Authors:  Jelena Zlatkovic-Lindor; D Kent Arrell; Satsuki Yamada; Timothy J Nelson; Andre Terzic
Journal:  Stem Cells       Date:  2010-08       Impact factor: 6.277

Review 5.  Cardiogenesis: an embryological perspective.

Authors:  Ramón Muñoz-Chápuli; José M Pérez-Pomares
Journal:  J Cardiovasc Transl Res       Date:  2009-11-04       Impact factor: 4.132

Review 6.  Strategies for organ level tissue engineering.

Authors:  Kristine C Rustad; Michael Sorkin; Benjamin Levi; Michael T Longaker; Geoffrey C Gurtner
Journal:  Organogenesis       Date:  2010 Jul-Sep       Impact factor: 2.500

Review 7.  Very small embryonic-like stem cells in cardiovascular repair.

Authors:  Wojciech Wojakowski; Magda Kucia; Ewa Zuba-Surma; Tomasz Jadczyk; Beata Książek; Mariusz Z Ratajczak; Michał Tendera
Journal:  Pharmacol Ther       Date:  2010-10-31       Impact factor: 12.310

8.  Therapeutic effects of induced pluripotent stem cells in chimeric mice with β-thalassemia.

Authors:  Guanheng Yang; Wansheng Shi; Xingyin Hu; Jingzhi Zhang; Zhijuan Gong; Xinbing Guo; Zhaorui Ren; Fanyi Zeng
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

9.  Selection via pluripotency-related transcriptional screen minimizes the influence of somatic origin on iPSC differentiation propensity.

Authors:  Katherine A Hartjes; Xing Li; Almudena Martinez-Fernandez; Alexa J Roemmich; Brandon T Larsen; Andre Terzic; Timothy J Nelson
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

10.  Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells.

Authors:  Clifford D L Folmes; Almudena Martinez-Fernandez; Randolph S Faustino; Satsuki Yamada; Carmen Perez-Terzic; Timothy J Nelson; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2012-12-18       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.